INSPIRE TO MAKE A DIFFERENCE
INSPIRING YOU TO
BE AN INSPIRATION
We do not have to go too far in our quest for inspiration. It exists around us, within us, and just needs to be ignited to begin something new. Here is a glimpse of some of our most inspirational stories. We learn from them, wear them proudly and tell them to the world, as we believe there is nothing quite like Glenmark.
The Glenmark Foundation demonstrates an unwavering commitment to giving back to society by focussing on improving health standards within the communities. The foundation supports projects that help in creating sustainable livelihood, providing access to healthcare for the underprivileged and enriching lives to create a healthier and happier world through our employee volunteering initiative of Glenmark Joy of Giving initiative.
Our employees from Czech Republic have registered as bone marrow donors
Teams from Kazakhstan underlined their care towards children suffering from cerebral palsy and cancer
Kurkumbh and Mohol sites supported a shelter home by providing care for children affected by HIV/AIDS
Through the years, 40 Glenmark locations across 24 countries have been celebrating the annual festival of philanthropy. The focus areas for which have been digitization of classrooms, donation of food grains and school requirements, setting up of libraries, competitions and sessions to educate on health, nutrition and hygiene and building upcycled playgrounds.
Glenmark Europe started in late 2000s with generic and branded generics business. While the business grew to more than USD 140 million, the ambition of Glenmark Europe was to align with the focused therapeutic segments of the company globally. Respiratory was one such area.
The target was and still is to commercialize the biggest products in the respiratory device segment. Fluticasone and Salmeterol DPI or Seretide was amongst the biggest in Europe with sales of about USD 1 billion and presented us with a huge opportunity. The search for a generic version of Seretide Accuhaler product – Fluticasone/Salmeterol DPI in Europe ended with the identification of a local Polish company called Celon Pharmaceuticals in late 2014. Glenmark signed a licensing and supply agreement with Celon in 2015 through which Glenmark obtained semi-exclusive marketing and distribution rights for the product across 15 European countries.
We embarked upon an innovative phased registration strategy, while development and studies continued in parallel. There were a number of challenges to ensure we secured registrations but our cross-functional teams remained committed. Finally their efforts resulted in Glenmark successfully completing the registration of the product in Nordic countries in 2018.
Not only registration, but Glenmark was also the first company to get substitution granted in Denmark, Norway and Sweden for a DPI giving us a huge competitive advantage. The commercial team in Nordics did an excellent job, and the product is already on track to be the biggest launch in the history of Glenmark Europe. The story is not complete yet, and launches in other key markets are expected shortly.
Site Ankleshwar supported local schools with educational materials
The Head Office and India Formulations teams built upcycled playgrounds for Government schools and digital classrooms
Our Sikkim employees extended support towards local schools
To support mother and child heath, Glenmark Foundation has initiated several interventions that are aimed at encouraging behaviour change and addressing issues related to pregnancy, new-born and child health and facilitating access to obstetric and new-born care at public and private facilities.
Mothers and children attending a health awareness session
Health workers celebrating children’s day with our beneficiaries
Villagers attending a workshop on making the smokeless chulha